Brief: Urogen Pharma Reports $1.35 Q3 Loss Per Share

UroGen Pharma

15/11/2021 13:22

Nov 15 (Reuters) - Urogen Pharma Ltd  URGN.O :
    * UROGEN PHARMA REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS
AND
RECENT CORPORATE DEVELOPMENTS
    * Q3 LOSS PER SHARE $1.35
    * SEES FULL YEAR 2021 REVENUE GUIDANCE OF $47 MILLION TO $51
MILLION
    * QTRLY REVENUE $11.35 MILLION VERSUS $3.46 MILLION
    * Q3 EARNINGS PER SHARE VIEW $-1.29, REVENUE VIEW $15.4
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nBw65DpNVa 
Further company coverage:  URGN.O 

 ((Reuters.Briefs@thomsonreuters.com;))